Kidney cancer: post-surgery sorafenib
0 Bekeken
• 06/26/23
0
0
insluiten
administrator
abonnees
Tim Eisen, MBBChir, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, describes the rationale and methodology behind the SORCE trial (NCT00492258) and what have we learned at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties